Randomized Phase II Trial of the Sequences of Anthracyline and Taxane in Locally Advanced Breast Cancer.

Trial Profile

Randomized Phase II Trial of the Sequences of Anthracyline and Taxane in Locally Advanced Breast Cancer.

Active, no longer recruiting
Phase of Trial: Phase II

Latest Information Update: 05 Jun 2018

At a glance

  • Drugs Docetaxel (Primary) ; Cyclophosphamide; Doxorubicin; Fluorouracil
  • Indications Advanced breast cancer
  • Focus Therapeutic Use
  • Acronyms NeoSAMBA
  • Most Recent Events

    • 05 Jun 2018 Results presented at the 54th Annual Meeting of the American Society of Clinical Oncology
    • 15 Nov 2017 Planned End Date changed from 1 Dec 2016 to 1 Dec 2018.
    • 15 Nov 2017 Planned primary completion date changed from 1 Sep 2016 to 1 Apr 2018.
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at AsktheExpert.AdisInsight@springer.com so we can help.

Back to top